4-(2-methoxy-1-naphthyl)-1,3-thiazol-2-amine, 95.0%, 1g

((2R,3R,5R)-3-(benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate, 97%, 1g

4-(Azetidin-3-yl)morpholine hydrochloride, 95.0%, 1g

TERT-BUTYL AZETIDINE-3-CARBOXYLATE HOAC, 95.0%, 250mg

(2R,3S)-1-tert-butyl 3-ethyl 2-(4-(cyclopentylamino)phenyl)piperidine-1,3-dicarboxylate, 97%, 50mg

Heparin sodium salt, min. 180 IU/mg, Ph.Eur., from porcine intestinal mucosa, 25 g

tert-Butyl 1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 95.0%, 5g

(4aS,7aR)-Octahydrocyclopenta[b][1,4]oxazine hydrochloride, 98%, 500mg

Methoxymethyl Phenyl Sulfone>98.0%(GC)5g

rel-(3R,4S)-1-(tert-Butoxycarbonyl)-4-(p-tolyl)pyrrolidine-3-carboxylic acid, 98%, 5g

Diethyl glutarate, 95.0%, 5g

Silicon Target 99.999% dia. 50.8 mm x thickness 3.18 mm 1 pc

N-(BUT-3-ENYL)-2,2,2-TRIFLUOROACETAMIDE, 95.0%, 5g